Neckers L - Search Results

1

Proceedings of the Oxygen Homeostasis/Hypoxia Meeting.

Kaufman B, Scharf O, Arbeit J, Ashcroft M, Brown JM, Bruick RK, Chapman JD, Evans SM, Giaccia AJ, Harris AL, Huang E, Johnson R, Kaelin W Jr, Koch CJ, Maxwell P, Mitchell J, Neckers L, Powis G, Rajendran J, Semenza GL, Simons J, Storkebaum E, Welch MJ, Whitelaw M, Melillo G, Ivy SP. Kaufman B, et al. Among authors: neckers l. Cancer Res. 2004 May 1;64(9):3350-6. doi: 10.1158/0008-5472.can-03-2611. Cancer Res. 2004. PMID: 15126380 No abstract available.

2

Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.

Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT. Sandlund JT, et al. Among authors: neckers lm. Cancer Res. 1993 Jan 1;53(1):127-32. Cancer Res. 1993. PMID: 8416737

3

Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.

Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Blagosklonny MV, et al. Among authors: neckers lm. Cancer Res. 1996 Apr 15;56(8):1851-4. Cancer Res. 1996. PMID: 8620503

4

Regulation of BRCA1 by protein degradation.

Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM. Blagosklonny MV, et al. Among authors: neckers lm. Oncogene. 1999 Nov 11;18(47):6460-8. doi: 10.1038/sj.onc.1203068. Oncogene. 1999. PMID: 10597248

5

Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.

Garayoa M, Martínez A, Lee S, Pío R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M, Cuttitta F. Garayoa M, et al. Among authors: neckers l. Mol Endocrinol. 2000 Jun;14(6):848-62. doi: 10.1210/mend.14.6.0473. Mol Endocrinol. 2000. PMID: 10847587

6

Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.

Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM. Bonvini P, et al. Among authors: neckers lm. Cancer Res. 2001 Feb 15;61(4):1671-7. Cancer Res. 2001. PMID: 11245482

7

Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.

Neckers L. Neckers L. Clin Cancer Res. 2002 May;8(5):962-6. Clin Cancer Res. 2002. PMID: 12006507 No abstract available.

8

Heat shock protein 90.

Neckers L, Ivy SP. Neckers L, et al. Curr Opin Oncol. 2003 Nov;15(6):419-24. doi: 10.1097/00001622-200311000-00003. Curr Opin Oncol. 2003. PMID: 14624223 Review.

9

The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.

Xu W, Yuan X, Jung YJ, Yang Y, Basso A, Rosen N, Chung EJ, Trepel J, Neckers L. Xu W, et al. Among authors: neckers l. Cancer Res. 2003 Nov 15;63(22):7777-84. Cancer Res. 2003. PMID: 14633703

10

Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.

Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D. Bisht KS, et al. Among authors: neckers lm. Cancer Res. 2003 Dec 15;63(24):8984-95. Cancer Res. 2003. PMID: 14695217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page